Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
385M
-
Number of holders
-
1062
-
Total 13F shares, excl. options
-
241M
-
Shares change
-
+5.28M
-
Total reported value, excl. options
-
$61B
-
Value change
-
+$683M
-
Put/Call ratio
-
1.47
-
Number of buys
-
503
-
Number of sells
-
-599
-
Price
-
$253.98
Significant Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q4 2021
1,398 filings reported holding MRNA - Moderna, Inc. - COMMON STOCK as of Q4 2021.
Moderna, Inc. - COMMON STOCK (MRNA) has 1,062 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 241M shares
of 385M outstanding shares and own 62.55% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (45.8M shares), BlackRock Inc. (27.7M shares), VANGUARD GROUP INC (27.4M shares), Flagship Pioneering Inc. (17.6M shares), STATE STREET CORP (14.9M shares), GEODE CAPITAL MANAGEMENT, LLC (6.03M shares), Theleme Partners LLP (5.02M shares), MORGAN STANLEY (4.84M shares), COATUE MANAGEMENT LLC (4.29M shares), and NORTHERN TRUST CORP (3.48M shares).
This table shows the top 1062 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.